Figure 3From: Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis HOXA9 is methylated and expressed at low levels in oral cancer cell lines. a. Methylation levels (mean and standard deviation) as determined by pyrosequencing. b. Transcript levels determined by quantitative RT-PCRBack to article page